Instrument Inactif

Autres langues Novavax, Inc. Nasdaq

Actions

US6700021040

Recherche biotechnologique et médicale

Autres langues

06/08	Novavax, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08	Earnings Flash (NVAX) Novavax Posts Q2 Net Loss of $0.32 a Share, vs. FactSet Est. of $0.38 Loss
06/08	Earnings Flash (NVAX) Novavax, Inc. Reports Q2 Revenue $56.7M, vs. FactSet Est of $52.5M
06/08	Novavax: Q2 Earnings Snapshot
06/08	Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
06/08	Novavax raises annual revenue forecast as licensing bets offset weak vaccine demand
30/07	Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
29/06	Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell Small Cap Comp Growth Benchmark
29/06	Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell 2500 Growth Benchmark
29/06	Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell 2000 Growth Benchmark
29/06	Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell 3000E Growth Benchmark
29/06	Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell 3000 Growth Benchmark
01/06	Novavax to Participate in 2026 Jefferies Global Healthcare Conference
28/05	FDA advisers recommend COVID vaccines be updated to target current dominant variant
26/05	US FDA advisers to weigh updating 2026-27 COVID vaccines for XFG variant
15/05	Coatue Management cuts share stake in Tesla by 96.4%, SEC filing shows
15/05	Shah Capital Management will vote 'No' across five proposals on Novavax's June 18 ballot - SEC filing
15/05	Shah Capital Management Sent a Presentation to the Board of Novavax, Inc
07/05	Novavax to Participate in BofA Securities 2026 Health Care Conference
06/05	Novavax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
06/05	Novavax Shares Rise After Narrower-Than-Expected Q1 Net Loss
06/05	Novavax : Q1 Reports & Financials (nvax q1 2026 earnings presentation)
06/05	Earnings Flash (NVAX) Novavax Posts Q1 Net Loss $0.06 a Share, vs. FactSet Est of $0.24 Loss
06/05	Earnings Flash (NVAX) Novavax, Inc. Reports Q1 Revenue $139.5M, vs. FactSet Est of $79.8M
06/05	Novavax beats first-quarter revenue estimates on strength in vaccine deals